Development of the immune response in pneumonia induced by Staphylococcus aureus (part 3)

A.E. Abaturov, A.A. Nikulinа


The article analyzes the key role of pro-inflammatory and anti-inflammatory cytokines in the development of immune response in pneumonia caused by Staphylococcus aureus based on the literature data. Genes associated with a predisposition to staphylococcal infection and/or determining its course are considered. Signal pathways inducing the production of interferons I, II and III type participating in elimination of Staphylococcus aureus are described.


pneumonia; Staphylococcus aureus; cytokines; interferons I, II and III types


Ahn DS, Parker D, Planet PJ. Secretion of IL-16 through TNFR1 and calpain-caspase signaling contributes to MRSA pneumonia. Mucosal Immunol. 2014 Nov;7(6):1366-74. doi: 10.1038/mi.2014.24.

Alijotas-Reig J, Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R et al. Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review. Clin Rev Allergy Immunol. 2017 Jan 4. doi: 10.1007/s12016-016-8596-x.

Anderson M, Ohr RJ, Aly KA et al. EssE Promotes Staphylococcus aureus ESS-Dependent Protein Secretion To Modify Host Immune Responses during Infection. J Bacteriol. 2017 Jan 1;199(1). pii: e00527-16. doi: 10.1128%2FJB.00527-16.

Archer NK, Adappa ND, Palmer JN et al. Interleukin-17A (IL-17A) and IL-17F Are Critical for Antimicrobial Peptide Production and Clearance of Staphylococcus aureus Nasal Colonization. Infect Immun. 2016 Nov 18;84(12):3575-3583. doi: 10.1128/IAI.00596-16.

Archer NK, Harro JM, Shirtliff ME. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect Immun. 2013 Jun;81(6):2070-5. doi: 10.1128/IAI.00084-13.

Aufiero B, Guo M, Young C et al. Staphylococcus aureus induces the expression of tumor necrosis factor-alpha in primary human keratinocytes. Int J Dermatol. 2007 Jul;46(7):687-94. doi: 10.1111/j.1365-4632.2007.03161.x.

Ballinger MN, Standiford TJ. Postinfluenza bacterial pneumonia: host defenses gone awry. J Interferon Cytokine Res. 2010 Sep;30(9):643-52. doi: 10.1089/jir.2010.0049.

Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol. 2009 Nov;10(11):1200-7. doi: 10.1038/ni.1792.

Bean AG, Freiberg RA, Andrade S et al. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect Immun. 1993 Nov;61(11):4937-PMID: 8406900.  PMC: PMC281261.

Blazek K, Eames HL, Weiss M et al. IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production. J Exp Med. 2015 Jun 1;212(6):845-53. doi: 10.1084/jem.20140995.

Borges da Silva H, Fonseca R, Alvarez JM, D'Império Lima MR. IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases. J Immunol Res. 2015;2015:202816. doi: 10.1155/2015/202816.

Bowdridge S, Gause WC. Regulation of alternative macrophage activation by chromatin remodeling. Nat Immunol. 2010 Oct;11(10):879-81. doi: 10.1038/ni1010-879.

Brabcová E, Kolesár L, Thorburn E, Stříž I. Chemokines induced in human respiratory epithelial cells by IL-1 family of cytokines. Folia Biol (Praha). 2014;60(4):180-6. PMID: 25152051.

Camporeale A, Poli V. IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? Front Biosci (Landmark Ed). 2012 Jun 1;17:2306-26. doi: 10.2741/4054.

Capobianchi MR, Uleri E, Caglioti C, Dolei A. Type I IFN family members: similarity, differences and interaction. Cytokine Growth Factor Rev. 2015 Apr;26(2):103-11. doi: 10.1016/j.cytogfr.2014.10.011.

Casbon AJ, Long ME, Dunn KW et al. Effects of IFN-γ on intracellular trafficking and activity of macrophage NADPH oxidase flavocytochrome b558. J Leukoc Biol. 2012 Oct;92(4):869-82. doi: 10.1189/jlb.0512244.

Chau TA, McCully ML, Brintnell W et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med. 2009 Jun;15(6):641-8. doi: 10.1038/nm.1965.

Chen CC, Kobayashi T, Iijima K et al. IL-33 dysregulates regulatory T (Treg) cells and impairs established immunological tolerance in the lungs. J Allergy Clin Immunol. 2017 Feb 11. pii: S0091-6749(17)30228-2. doi: 10.1016/j.jaci.2017.01.015.

Chen YG, Zhang Y, Deng LQ et al. Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4. PLoS One. 2016 Mar 14;11(3):e0149233. doi: 10.1371/journal.pone.0149233.

Cheng P, Liu T, Zhou WY et al. Role of gamma-delta T cells in host response against Staphylococcus aureus-induced pneumonia. BMC Immunol. 2012 Jul 9;13:38. doi: 10.1186/1471-2172-13-38.

Choi SM, McAleer JP, Zheng M et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia. J Exp Med. 2013 Mar 11;210(3):551-61. doi: 10.1084/jem.20120260.

Chow AW. Adjuvant anti-tumor necrosis factor therapy for staphylococcal arthritis and sepsis: a cautionary note. J Infect Dis. 2011 Aug 1;204(3):332-4. doi: 10.1093/infdis/jir272.

Cohen TS, Parker D. Microbial pathogenesis and type III interferons. Cytokine Growth Factor Rev. 2016 Jun;29:45-51. doi: 10.1016/j.cytogfr.2016.02.005.

Cohen TS, Prince AS. Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4. PLoS Pathog. 2013;9(10):e1003682. doi: 10.1371/journal.ppat.1003682.

Cortez VS, Colonna M. Diversity and function of group 1 innate lymphoid cells. Immunol Lett. 2016 Nov;179:19-24. doi: 10.1016/j.imlet.2016.07.005.

Debes GF, Dahl ME, Mahiny AJ et al. Chemotactic responses of IL-4-, IL-10-, and IFN-gamma-producing CD4+ T cells depend on tissue origin and microbial stimulus. J Immunol. 2006 Jan 1;176(1):557-66. doi: 10.4049/jimmunol.176.1.557.

Dietert K, Reppe K, Mundhenk L, Witzenrath M, Gruber AD. mCLCA3 modulates IL-17 and CXCL-1 induction and leukocyte recruitment in murine Staphylococcus aureus pneumonia. PLoS One. 2014 Jul 17;9(7):e102606. doi: 10.1371/journal.pone.0102606.

Diveu C, McGeachy MJ, Boniface K et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol. 2009 May 1;182(9):5748-56. doi: 10.4049/jimmunol.0801162.

Doodes PD, Cao Y, Hamel KM et al. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol. 2010 Feb 1;184(3):1552-9. doi: 10.4049/jimmunol.0902907.

Fox JM, Crabtree JM, Sage LK et al. Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection. J Interferon Cytokine Res. 2015 Jul;35(7):554-62. doi: 10.1089/jir.2014.0052.

Frodermann V, Chau TA, Sayedyahossein S et al. A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis. 2011 Jul 15;204(2):253-62. doi: 10.1093/infdis/jir276.

Furukawa S, Moriyama M, Miyake K et al. Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep. 2017 Feb 13;7:42413. doi: 10.1038/srep42413.

Galani IE, Koltsida O, Andreakos E. Type III interferons (IFNs): Emerging Master Regulators of Immunity. Adv Exp Med Biol. 2015;850:1-15. doi: 10.1007/978-3-319-15774-0_1.

Gauguet S, D'Ortona S, Ahnger-Pier K et al. Intestinal Microbiota of Mice Influences Resistance to Staphylococcus aureus Pneumonia. Infect Immun. 2015 Oct;83(10):4003-14. doi: 10.1128/IAI.00037-15.

Giai C, Gonzalez C, Ledo C et al. Shedding of tumor necrosis factor receptor 1 induced by protein A decreases tumor necrosis factor alpha availability and inflammation during systemic Staphylococcus aureus infection. Infect Immun. 2013 Nov;81(11):4200-7. doi: 10.1128/IAI.00593-13.

Gómez MI, Lee A, Reddy B et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med. 2004 Aug;10(8):842-8. doi: 10.1038/nm1079.

Greenlee-Wacker MC, Nauseef WM. IFN-γ targets macrophage-mediated immune responses toward Staphylococcus aureus. J Leukoc Biol. 2016 Oct 5. pii: jlb.4A1215-565RR. PMC: PMC5295848.

Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011 Feb;89(2):207-15. doi: 10.1038/icb.2010.158.

Hall G, Cullen E, Sawmynaden K et al. Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): mechanistic insights and new therapeutic opportunities. J Biol Chem. 2016 Aug 5;291(32):16840-8. doi: 10.1074/jbc.M115.709303.

Held J, Preuße C, Döser A et al. Enhanced acute immune response in IL-12p35-/- mice is followed by accelerated distinct repair mechanisms in Staphylococcus aureus-induced murine brain abscess. J Infect Dis. 2013 Sep 1;208(5):749-60. doi: 10.1093/infdis/jit126.

Hernández PP, Mahlakõiv T, Yang I et al. Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol. 2015 Jul;16(7):698-707. doi: 10.1038/ni.3180.

Hu X, Chakravarty SD, Ivashkiv LB. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol Rev. 2008 Dec;226:41-56. doi: 10.1111/j.1600-065X.2008.00707.x.

Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity. 2009 Oct 16;31(4):539-50. doi: 10.1016/j.immuni.2009.09.002.

Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015 May;16(5):448-57. doi: 10.1038/ni.3153.

Hunter CA, Kastelein R. Interleukin-27: balancing protective and pathological immunity. Immunity. 2012 Dec 14;37(6):960-9. doi: 10.1016/j.immuni.2012.11.003.

Huys L, Van Hauwermeiren F, Dejager L et al. Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med. 2009 Aug 31;206(9):1873-82. doi: 10.1084/jem.20090213.

Ishigame H, Kakuta S, Nagai T et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009 Jan 16;30(1):108-19. doi: 10.1016/j.immuni.2008.11.009.

Jacqueline C, Broquet A, Roquilly A et al. Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages. J Infect Dis. 2014 Sep 1;210(5):814-23. doi: 10.1093/infdis/jiu145.

Joost I, Steinfurt J, Meyer PT et al. Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab. BMC Infect Dis. 2016 Oct 20;16(1):586. doi: 10.1186/s12879-016-1912-5.

Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016 Jan;12(1):49-62. doi: 10.1038/nrrheum.2015.169.

Keck S, Freudenberg M, Huber M. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol. 2010 May 15;184(10):5809-18. doi: 10.4049/jimmunol.0901423.

KleinJan A. Airway inflammation in asthma: key players beyond the Th2 pathway. Curr Opin Pulm Med. 2016 Jan;22(1):46-52. doi: 10.1097/MCP.0000000000000224.

Kovarik P, Castiglia V, Ivin M, Ebner F. Type I Interferons in Bacterial Infections: A Balancing Act. Front Immunol. 2016 Dec 26;7:652. doi: 10.3389/fimmu.2016.00652.

Kudva A, Scheller EV, Robinson KM et al. Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol. 2011 Feb 1;186(3):1666-74. doi: 10.4049/jimmunol.1002194.

Labrousse D, Perret M, Hayez D et al. Kineret®/IL-1ra blocks the IL-1/IL-8 inflammatory cascade during recombinant Panton Valentine Leukocidin-triggered pneumonia but not during S. aureus infection. PLoS One. 2014 Jun 6;9(6):e97546. doi: 10.1371/journal.pone.0097546.

Lambrecht BN, Hammad H. Asthma: the importance of dysregulated barrier immunity. Eur J Immunol. 2013 Dec;43(12):3125-37. doi: 10.1002/eji.201343730.

Lan F, Yuan B, Liu T et al. Interleukin-33 facilitates neutrophil recruitment and bacterial clearance in S. aureus-caused peritonitis. Mol Immunol. 2016 Apr;72:74-80. doi: 10.1016/j.molimm.2016.03.004.

Lazear HM, Nice TJ, Diamond MS. Interferon-λ: Immune Functions at Barrier Surfaces and Beyond. Immunity. 2015 Jul 21;43(1):15-28. doi: 10.1016/j.immuni.2015.07.001.

Leech JM, Lacey KA, Mulcahy ME et al. IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. J Immunol. 2017 Feb 6. pii: 1601018. doi: 10.4049/jimmunol.1601018.

Leemans JC, Vervoordeldonk MJ, Florquin S et al. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med. 2002 May 15;165(10):1445-50. doi: 10.1164/rccm.2106045.

Li L, Shi QG, Lin F et al. Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease. Mol Med Rep. 2014 Mar;9(3):831-6. doi: 10.3892/mmr.2014.1898.

Li Z, Peres AG, Damian AC, Madrenas J. Immunomodulation and Disease Tolerance to Staphylococcus aureus. Pathogens. 2015 Nov 13;4(4):793-815. doi: 10.3390/pathogens4040793.

Little FF, Cruikshank WW. Interleukin-16 and peptide derivatives as immunomodulatory therapy in allergic lung disease. Expert Opin Biol Ther. 2004 Jun;4(6):837-46. doi: 10.1517/14712598.4.6.837.

Lloyd CM, Saglani S. Epithelial cytokines and pulmonary allergic inflammation. Curr Opin Immunol. 2015 Jun;34:52-8. doi: 10.1016/j.coi.2015.02.001.

Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001 Feb 23;104(4):487-501. doi: 10.1016/S0092-8674(01)00237-9.

Luo Y, Zheng SG. Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms. Front Immunol. 2016 Dec 19;7:604. doi: 10.3389/fimmu.2016.00604.

Maher BM, Mulcahy ME, Murphy AG et al. Nlrp-3-driven interleukin 17 production by γδT cells controls infection outcomes during Staphylococcus aureus surgical site infection. Infect Immun. 2013 Dec;81(12):4478-89. doi: 10.1128/IAI.01026-13.

Majoros A, Platanitis E, Kernbauer-Hölzl E et al. Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses. Front Immunol. 2017 Jan 26;8:29. doi: 10.3389/fimmu.2017.00029.

Martin FJ, Parker D, Harfenist BS et al. Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun. 2011 May;79(5):1898-904. doi: 10.1128/IAI.01299-10.

Martin FJ, Gomez MI, Wetzel DM et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest. 2009 Jul;119(7):1931-9. doi: 10.1172/JCI35879.

McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015 Feb;15(2):87-103. doi: 10.1038/nri3787.

Mendoza Bertelli A, Delpino MV, Lattar S et al. Staphylococcus aureus protein A enhances osteoclastogenesis via TNFR1 and EGFR signaling. Biochim Biophys Acta. 2016 Oct;1862(10):1975-83. doi: 10.1016/j.bbadis.2016.07.016.

Mingomataj EÇ, Bakiri AH. Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response. Clin Rev Allergy Immunol. 2016 Feb;50(1):97-113. doi: 10.1007/s12016-015-8514-7.

Monticelli LA, Osborne LC, Noti M et al. L-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):10762-7. doi: 10.1073/pnas.1509070112.

Mordstein M, Michiels T, Staeheli P. What have we learned from the IL28 receptor knockout mouse? J Interferon Cytokine Res. 2010 Aug;30(8):579-84. doi: 10.1089/jir.2010.0061.

Mulcahy ME, McLoughlin RM. Staphylococcus aureus and Influenza A Virus: Partners in Coinfection. MBio. 2016 Dec 13;7(6). pii: e02068-16. doi: 10.1128/mBio.02068-16.

Mulcahy ME, McLoughlin RM. Host-Bacterial Crosstalk Determines Staphylococcus aureus Nasal Colonization. Trends Microbiol. 2016 Nov;24(11):872-86. doi: 10.1016/j.tim.2016.06.012.

Murphy M, Xiong Y, Pattabiraman G, Qiu F, Medvedev AE. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance. J Biol Chem. 2015 Jul 31;290(31):19218-32. doi: 10.1074/jbc.M115.640128.

Nguyen QT, Furuya Y, Roberts S, Metzger DW. Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2015 Oct;59(10):6308-16. doi: 10.1128/AAC.00968-15.

Ni G, Wang T, Walton S et al. Manipulating IL-10 signalling blockade for better immunotherapy. Cell Immunol. 2015 Feb;293(2):126-9. doi: 10.1016/j.cellimm.2014.12.012.

Ning R, Zhang X, Guo X, Li Q. Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappaB signaling pathway in human osteoblasts. Braz J Infect Dis. 2011 May-Jun;15(3):189-94. PMID: 21670915.

Okano M, Fujiwara T, Kariya S et al. Staphylococcal protein A-formulated immune complexes suppress enterotoxin-induced cellular responses in nasal polyps. J Allergy Clin Immunol. 2015 Aug;136(2):343-50.e8. doi: 10.1016/j.jaci.2014.10.058.

Ouyang W, Rutz S, Crellin NK et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29:71-109. doi: 10.1146/annurev-immunol-031210-101312.

Paczosa MK, Mecsas J. Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016 Jun 15;80(3):629-61. doi: 10.1128/MMBR.00078-15.

Paolini R, Bernardini G, Molfetta R, Santoni A. NK cells and interferons. Cytokine Growth Factor Rev. 2015 Apr;26(2):113-20. doi: 10.1016/j.cytogfr.2014.11.003.

Parker D, Planet PJ, Soong G et al. Induction of type I interferon signaling determines the relative pathogenicity of Staphylococcus aureus strains. PLoS Pathog. 2014 Feb 20;10(2):e1003951. doi: 10.1371/journal.ppat.1003951.

Parker D, Ahn D, Cohen T, Prince A. Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev. 2016 Jan;96(1):19-53. doi: 10.1152/physrev.00009.2015.

Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol. 2011 Aug;45(2):189-201. doi: 10.1165/rcmb.2011-0011RT.

Parker D, Prince A. Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol. 2012 Oct 15;189(8):4040-6. doi: 10.4049/jimmunol.1201055.

Parker D, Prince A. Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol. 2011 Dec;32(12):582-8. doi: 10.1016/

Pesic G, Jeremic J, Nikolic T et al. Interleukin-6 as possible early marker of stress response after femoral fracture. Mol Cell Biochem. 2017 Feb 16. doi: 10.1007/s11010-017-2967-3.

Planet PJ, Parker D, Cohen TS et al. Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection. MBio. 2016 Feb 9;7(1):e01939-15. doi: 10.1128/mBio.01939-15.

Puimège L, Libert C, Van Hauwermeiren F. Regulation and dysregulation of tumor necrosis factor receptor-1. Cytokine Growth Factor Rev. 2014 Jun;25(3):285-300. doi: 10.1016/j.cytogfr.2014.03.004.

Reid E, Charleston B. Type I and III interferon production in response to RNA viruses. J Interferon Cytokine Res. 2014 Sep;34(9):649-58. doi: 10.1089/jir.2014.0066.

Robinson KM, Choi SM, McHugh KJ et al. Influenza A exacerbates Staphylococcus aureus pneumonia by attenuating IL-1β production in mice. J Immunol. 2013 Nov 15;191(10):5153-9. doi: 10.4049/jimmunol.1301237.

Robinson KM, Lee B, Scheller EV et al. The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia. Respir Res. 2015 Feb 5;16:10. doi: 10.1186/s12931-015-0168-8.

Rose WE, Shukla SK, Berti AD et al. Increased Endovascular Staphylococcus aureus Inoculum is the Link between Elevated Serum IL-10 Concentrations and Mortality in Patients with Bacteremia. Clin Infect Dis. 2017 Feb 16;64(10):1406-12. doi: 10.1093/cid/cix157.

Rubini A. Interleukin-6 and lung inflammation: evidence for a causative role in inducing respiratory system resistance increments. Inflamm Allergy Drug Targets. 2013 Oct;12(5):315-21. doi: 10.2174/1871528111312050003.

Rutz S, Ouyang W. Regulation of interleukin-10 and interleukin-22 expression in T helper cells. Curr Opin Immunol. 2011 Oct;23(5):605-12. doi: 10.1016/j.coi.2011.07.018.

Rynda-Apple A, Harmsen A, Erickson AS et al. Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Eur J Immunol. 2014 Nov;44(11):3263-72. doi: 10.1002/eji.201444582.

Rynda-Apple A, Dobrinen E, McAlpine M et al. Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function. Am J Pathol. 2012 Jul;181(1):196-210. doi: 10.1016/j.ajpath.2012.03.018.

Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun. 2015 Oct;83(10):3764-70. doi: 10.1128/IAI.00298-15.

Sabat R, Grütz G, Warszawska K et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010 Oct;21(5):331-44. doi: 10.1016/j.cytogfr.2010.09.002.

Santos-Sierra S, Deshmukh SD, Kalnitski J et al. Mal connects TLR2 to PI3Kinase activation and phagocyte polarization. EMBO J. 2009 Jul 22;28(14):2018-27. doi: 10.1038/emboj.2009.158.

Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010 Mar;10(3):170-81. doi: 10.1038/nri2711.

Satorres SE, Alcaráz LE, Cargnelutti E et al. IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus. Immunol Lett. 2009 Apr 27;123(2):185-8. doi: 10.1016/j.imlet.2009.03.003.

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011 May;1813(5):878-88. doi: 10.1016/j.bbamcr.2011.01.034.

Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004 Feb;75(2):163-89. doi: 10.1189/jlb.0603252.

Shahangian A, Chow EK, Tian X et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009 Jul;119(7):1910-20. doi: 10.1172/JCI35412.

Sharma S, Saikia B, Goel S et al. TH17 Cells in STAT3 Related Hyper-IgE Syndrome. Indian J Pediatr. 2016 Oct;83(10):1104-8. doi: 10.1007/s12098-016-2150-y.

Shepardson KM, Larson K, Morton RV et al. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. MBio. 2016 May 3;7(3). pii: e00506-16. doi: 10.1128/mBio.00506-16.

Shukla SK, Rose W, Schrodi SJ. Complex host genetic susceptibility to Staphylococcus aureus infections. Trends Microbiol. 2015 Sep;23(9):529-36. doi: 10.1016/j.tim.2015.05.008.

Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol. 2004 Mar 15;172(6):3377-81. doi: 10.4049/jimmunol.172.6.3377.

Soyka MB, Holzmann D, Basinski TM et al. The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses. PLoS One. 2015 May 1;10(5):e0123163. doi: 10.1371/journal.pone.0123163.

Swindle EJ, Brown JM, Rådinger M et al. Interferon-γ enhances both the anti-bacterial and the pro-inflammatory response of human mast cells to Staphylococcus aureus. Immunology. 2015 Nov;146(3):470-85. doi: 10.1111/imm.12524.

Tan Y, Kagan JC. Microbe-inducible trafficking pathways that control Toll-like receptor signaling. Traffic. 2017 Jan;18(1):6-17. doi: 10.1111/tra.12454.

Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014 Apr;2(4):288-94. doi: 10.1158/2326-6066.CIR-14-0022.

Togbe D, Schnyder-Candrian S, Schnyder B et al. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol. 2007 Dec;88(6):387-91. doi: 10.1111/j.1365-2613.2007.00566.x.

Tracey KJ, Beutler B, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470-4. doi: 10.1126/science.3764421.

Tsai HC, Velichko S, Hung LY, Wu R. IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. Clin Dev Immunol. 2013;2013:267971. doi: 10.1155/2013/267971.

Ulett GC, Adderson EE. Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity. Curr Immunol Rev. 2006 May;2(2):119-141. doi: 10.2174/157339506776843033.

Waters JP, Pober JS, Bradley JR. Tumour necrosis factor in infectious disease. J Pathol. 2013 Jun;230(2):132-47. doi: 10.1002/path.4187.

Wu C, Xue Y, Wang P et al. IFN-γ primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b. J Immunol. 2014 Sep 15;193(6):3036-44. doi: 10.4049/jimmunol.1302379.

Ye P, Garvey PB, Zhang P et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol. 2001 Sep;25(3):335-40. doi: 10.1165/ajrcmb.25.3.4424.

Yin H, Li X, Hu S et al. IL-33 promotes Staphylococcus aureus-infected wound healing in mice. Int Immunopharmacol. 2013 Oct;17(2):432-8. doi: 10.1016/j.intimp.2013.07.008.

Yosef N, Shalek AK, Gaublomme JT et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature. 2013 Apr 25;496(7446):461-8. doi: 10.1038/nature11981.

Zhang X, Shang W, Yuan J et al. Positive Feedback Cycle of TNFα Promotes Staphylococcal Enterotoxin B-Induced THP-1 Cell Apoptosis. Front Cell Infect Microbiol. 2016 Sep 21;6:109. doi: 10.3389/fcimb.2016.00109.

Zhang Y, Lv R, Hu X et al. The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice. Inflammation. 2017 Feb;40(1):285-294. doi: 10.1007/s10753-016-0479-z.

Zheng Y, Valdez PA, Danilenko DM et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008 Mar;14(3):282-9. doi: 10.1038/nm1720.

Zundler S, Neurath MF. Interleukin-12: Functional activities and implications for disease. Cytokine Growth Factor Rev. 2015 Oct;26(5):559-68. doi: 10.1016/j.cytogfr.2015.07.003.

Copyright (c) 2020 A.E. Abaturov, A.A. Nikulinа

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта